Koninklijke Philips

Type

Corporate investor

Status

Active

Location

Amsterdam, Netherlands

Total investments

22

Average round size

42M

Portfolio companies

21

Rounds per year

0.17

Lead investments

2

Follow on index

0.05

Exits

8

Areas of investment
InternetSoftwareInformation TechnologyHealth CareEnterprise SoftwareMedical DeviceMedicalSemiconductorElectronicsWireless

Summary

Koninklijke Philips appeared to be the Corporate Investor, which was created in 1891. The fund was located in Europe if to be more exact in The Netherlands. The main department of described Corporate Investor is located in the Amsterdam.

The typical case for the fund is to invest in rounds with 4-5 participants. Despite the Koninklijke Philips, startups are often financed by Johnson & Johnson Development Corporation, Debiopharm Group, Siemens Mustang Ventures. The meaningful sponsors for the fund in investment in the same round are Texas Instruments, Wellcome Trust, Wasserstein Adelson Ventures. In the next rounds fund is usually obtained by Birchmere Ventures, The Hillman Company, Lago Ventures Fund.

Speaking about the real fund results, this Corporate Investor is 8 percentage points less often commits exit comparing to other organizations. When the investment is from Koninklijke Philips the average startup value is 500 millions - 1 billion dollars. Deals in the range of 10 - 50 millions dollars are the general things for fund. The higher amount of exits for fund were in 2016. The fund is constantly included in less than 2 investment rounds annually. The top activity for fund was in 2000. Despite it in 2019 the fund had an activity. This Koninklijke Philips works on 0 percentage points more the average amount of lead investments comparing to the other organizations.

Among the most successful fund investment fields, there are Semiconductor, Health Care. Besides, a startup needs to be aged 4-5 years to get the investment from the fund. For fund there is no match between the location of its establishment and the land of its numerous investments - United States. Among the various public portfolio startups of the fund, we may underline Alien Technology, SpotLife, Geocast Network Systems The fund has exact preference in a number of founders of portfolio startups. In case when startup counts 4 or 5+ of the founder, the chance for it to get the investment is meager.

Show more

Investor highlights

Discover reliable insights

Find relevant VC investors, identify key contacts and secure funding opportunities.

Investments analytics

Analytics

Total investments
22
Lead investments
2
Exits
8
Rounds per year
0.17
Follow on index
0.05
Investments by industry
  • Health Care (10)
  • Software (8)
  • Information Technology (7)
  • Semiconductor (3)
  • Internet (3)
  • Show 35 more
Investments by region
  • United States (13)
  • China (2)
  • Japan (2)
  • Israel (3)
  • Switzerland (1)
  • Show 1 more
Peak activity year
2000
Number of Unicorns
1
Number of Decacorns
1

Discover reliable insights

Leverage validated data, identify key contacts and secure funding opportunities for your business.

Quantitative data

Avg. startup age at the time of investment
18
Avg. valuation at time of investment
296M
Group Appearance index
0.91
Avg. company exit year
11
Avg. multiplicator
3.05
Strategy success index
0.50

Need more data?

Get access to full data about investors, including their team, contact information, and historic data.

Latest deals

Company name Deal date Industry Deal stage Deal size Location
CVAid Medical 28 Feb 2022 Software, Artificial Intelligence, Health Care, Medical Device Early Stage Venture 4M Tel Aviv District, Tel Aviv-Yafo, Israel
How we get our data

At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).

Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.